FDA to refer to AI as ‘super intelligence’ going forward
The US Food and Drug Administration (FDA) announced that, as of Monday, it will use the term “super intelligence” instead of “artificial intelligence” in all official correspondence, public communications, websites, reports, and policy documents.
comments(0)
5-min edit window · permanent after that